Beam Therapeutics Eulerpool naujienos

Beam Therapeutics Eulerpool News

Beam Therapeutics akcijų naujienos

Beam Therapeutics stebi daugybė žurnalistų ir investuotojų visame pasaulyje. Naujausias Beam Therapeutics naujienas mes pateikiame čia.

• liepos 1 d. ·

  SeekingAlpha
  Beam Therapeutics: Slow Developmental Progress, But Promising Potential
• birželio 26 d. ·

  Yahoo
  Beam Therapeutics Announces First Patient Dosed in the Phase 1/2 Study of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD)
• birželio 26 d. ·

  Thefly.com
  Beam Therapeutics announces dosing of first patient with BEAM-302
• birželio 18 d. ·

  TipRanks
  Beam Therapeutics Stock (NASDAQ:BEAM): The Future of Gene Editing?
• birželio 18 d. ·

  TipRanks
  Beam Therapeutics (NASDAQ:BEAM): The Future of Gene Editing?
• birželio 18 d. ·

  TipRanks
  Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (MIRM), Beam Therapeutics (BEAM) and Ovid Therapeutics (OVID)
• birželio 14 d. ·

  Yahoo
  Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investigational Base Editing Therapeutic for Sickle Cell Disease
• birželio 14 d. ·

  Thefly.com
  Beam Therapeutics reports data from BEAM-101 trial
• birželio 12 d. ·

  Market News Video
  BEAM Crosses Above Key Moving Average Level
• birželio 6 d. ·

  Yahoo
  Why Is Beam Therapeutics (BEAM) Up 10.1% Since Last Earnings Report?